Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors
Jasna Klen, Vita Dolžan
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3451-3451
Open Access | Times Cited: 25

Showing 25 citing articles:

Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver
Philip N. Newsome, Phil Ambery
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. 1557-1565
Open Access | Times Cited: 70
Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease
Merita Rroji, Goce Spasovski
Biomedicines (2024) Vol. 12, Iss. 3, pp. 657-657
Open Access | Times Cited: 5
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review
Janet B. McGill, Irl B. Hirsch, Christopher G. Parkin, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1085-1098
Open Access | Times Cited: 5
Efficacy and safety of tirzepatide in patients with type 2 diabetes: A systematic review and meta-analysis
Yan Tang, Lin Zhang, Yuping Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Short-term cost-effectiveness analysis of tirzepatide for the treatment of type 2 diabetes in the United States
Xiaotong Zhang, Carrie McAdam Marx
Journal of Managed Care & Specialty Pharmacy (2023) Vol. 29, Iss. 3, pp. 276-284
Open Access | Times Cited: 11
Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4/MyD88/NF-kappaB pathway in diabetic kidney disease
Linjing Huang, Tingting Lin, Meizhen Shi, et al.
AJP Regulatory Integrative and Comparative Physiology (2024) Vol. 327, Iss. 4, pp. R410-R422
Open Access | Times Cited: 3
Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity
Bernardo Cuffaro, Denise Boutillier, Jérémy Desramaut, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1260-1260
Open Access | Times Cited: 7
GLP1R (glucagon-like-peptide-1 incretin receptor), diabetes and obesity phenotypes: An in silico approach revealed new pathogenic variants
Vinicius Matheus Knihs, Fabíola Branco Filippin-Monteiro
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 2, pp. 102956-102956
Closed Access | Times Cited: 2
Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature
Lampros Chrysavgis, Spyridon Kazanas, Konstantina Bafa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3832-3832
Open Access | Times Cited: 2
Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects
Anastasios Lymperopoulos, Jordana I. Borges, Renee A. Stoicovy
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 693-693
Open Access | Times Cited: 2
Polyphenol-Rich Beverage Consumption Affecting Parameters of the Lipid Metabolism in Healthy Subjects
Celina Rahn, Tamara Bakuradze, Simone Stegmüller, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 841-841
Open Access | Times Cited: 6
Genetic Variability of Incretin Receptors and Alcohol Dependence: A Pilot Study
Evangelia Eirini Tsermpini, Katja Goričar, Blanka Kores Plesničar, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 9
Fomentariol, a Fomes fomentarius Compound, Exhibits Anti-Diabetic Effects in Fungal Material: An In Vitro Analysis
Matjaž Ravnikar, Borut Štrukelj, Biljana Otašević, et al.
Nutraceuticals (2024) Vol. 4, Iss. 2, pp. 273-282
Open Access | Times Cited: 1
Cyclic adenosine monophosphate critically modulates cardiac GLP-1 receptor’s anti-inflammatory effects
Renee A. Stoicovy, Natalie Cora, Arianna Perez, et al.
Inflammation Research (2024)
Closed Access | Times Cited: 1
Spint1 disruption in mouse pancreas leads to glucose intolerance and impaired insulin production involving HEPSIN/MAFA
Hsin-Hsien Lin, I‐Shing Yu, Mingshan Cheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Strategies for Therapeutic Amelioration of Aberrant Plasma Zn2+ Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects
Spencer Regan-Smith, Rémi Fritzen, Stephen J. Hierons, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10302-10302
Open Access | Times Cited: 6
Noncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes
Sasanka Ramanadham, John Turk, Sushant Bhatnagar
Comprehensive physiology (2023), pp. 5023-5049
Closed Access | Times Cited: 2
Early effect of exenatide treatment on atherogenicity in patients with type 2 diabetes mellitus
Burak Menekşe, Adnan Batman
International Journal of Diabetes in Developing Countries (2023) Vol. 44, Iss. 1, pp. 200-209
Closed Access | Times Cited: 2
A mathematical model of obesity-induced type 2 diabetes and efficacy of anti-diabetic weight reducing drug
Nourridine Siewe, Avner Friedman
Journal of Theoretical Biology (2024) Vol. 581, pp. 111756-111756
Closed Access
Obesidad y riesgo cardiovascular: liraglutida y sus beneficios terapéuticos
Washington Moises Moreira Mendoza, Luis Enrique Bravo Vaca, Mayker Armando Carbo Bazurto, et al.
AlfaPublicaciones (2024) Vol. 6, Iss. 3.1, pp. 165-183
Open Access
The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review
Agata Sadowska, Elżbieta Poniedziałek‐Czajkowska, Radzisław Mierzyński
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17298-17298
Open Access | Times Cited: 1
Genetic variants of the glucagon-like receptor-1 in obesity
Anna Nikulina
European Journal of Clinical and Experimental Medicine (2023) Vol. 21, Iss. 4, pp. 682-691
Open Access | Times Cited: 1
Role of Glucagon-Like Peptide-1 Receptor Agonists on the Weight Loss of Individuals with Type 2 Diabetes: A Systematic Review
Huma Irfan, Namratha Pallipamu, Hadi Farhat, et al.
Cureus (2023)
Open Access
PERDA DE PESO ASSOCIADA AO USO DE SEMAGLUTIDA: EFICÁCIA E MECANISMO DE AÇÃO
André Matheus Carvalho Silva Leite, Leonardo Almeida Fraga, Thales Bueno Marques Pedroza Filho, et al.
Brazilian Journal of Implantology and Health Sciences (2023) Vol. 5, Iss. 5, pp. 3095-3103
Open Access
Noncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes
Sasanka Ramanadham, John Turk, Sushant Bhatnagar
Comprehensive physiology (2023) Vol. 13, Iss. 3, pp. 5023-5049
Closed Access
Page 1

Scroll to top